Growth hormone therapy in turner syndrome - Current uncertainties and future strategies

Hormone Research in Paediatrics

Volumn 48, Issue 5, 1997, Pages 35-44

  Donaldson, M D C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Estrogen; Final height; Growth hormone; Oxandrolone; Projected adult height; Turner syndrome

Indexed keywords

ESTROGEN; HUMAN GROWTH HORMONE; OXANDROLONE;

ADOLESCENT; ADULT; AUSTRIA; BELGIUM; BODY HEIGHT; CANADA; CONFERENCE PAPER; ESTROGEN THERAPY; EUROPE; FEMALE; FRANCE; GROWTH; HORMONAL THERAPY; HUMAN; JAPAN; NETHERLANDS; PRIORITY JOURNAL; SWEDEN; TURNER SYNDROME; UNITED KINGDOM;

GROWTH HORMONE; HUMANS; TURNER SYNDROME;

EID: 0030777828     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191327     Document Type: Article

References (25)

1. Rosenfeld RG, Hintz RL, Johanson AJ, et al: Methionyl human growth hormone and oxan-drolonc in Turner's syndrome: preliminary results of a prospective randomized trial. J Pe-diatr 1986:109,936-943.
2. Donaldson MDC: Jury still out on growth hormone for normal short stature and Turner’s syndrome. Lancet 1996:348:3-4.
3. Rochiccioli P, Chaussain JL: Final height in patients with Turner syndrome treated with growth hormone (n = 117): in Albertsson-Wik-land K. Ranke MB (eds): Turner syndrome in a life-span perspective. Amsterdam, Elsevier, 1995, pp 123-128.
4. Massa G, Optten BJ, De Muink Keizer-Schra-nta SMPF, Jansen M, Vulsma T, Oostdijk W, Waclkens, Wit JM, from the Dutch Growth Hormone Working Group: Treatment with two growth hormone regimes in girls with Turner syndrome: final height results. Horm Res 1995: 43:144-146, 225-230.
5. Van de Broek J, Massa GG, Attanasio A, Ma-tranga A, Chaussin J-L, Price D, Aarskog A, Wit J-M, and the European Study Group: Final height after long-term growth hormone treatment in Turner syndrome. J Pediatr 1995:127: 729-735.
6. Takano K, Shizumc K, Hibi I, Ogawa M, Okado Y, Suwa S, Tanaka T, Hizuka N, and the Committee for the treatment of Turner Syndrome: Long-term effects of growth hormone treatment on height in Tumer syndrome: results of a 6-ycar mu It ¡centre study in Japan. Horm Res 1995;43:141-143.
7. Heinrichs C, De Schepper J, Thomas M, Massa G, Craen M, Malvaux P, Emould C, François I, DuCaju M, Vandcweghe M, Thiry-Counson G, Macs M, Bourguignon JP, and members of the Belgian Study group for Pediatric Endocrinology: Final height in 46 girls with Turner syndrome treated with growth hormone in Belgium: evaluation of height recovery and predictive factors; in: Albcrtsson-Wikland K, Ranke MB (eds): Turner syndrome in a life-span perspective. Amsterdam. Elsevier. 1995. pp 137-147.
8. Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vlict G: Does growth hormone supplementation affect adult height in Turners syndrome? Lancet 1996:348:25-26.
9. Chu CE, Paterson WF, Kelnar CJH, Smail PJ, Greene SA, Donaldson MDC: Variable effect of growth hormone on grow th and final adult height in Scottish patients with Turner’s syndrome. Acta Paediatr 1997;86:160-164.
10. Nilsson KO, Albertsson-Wikland K, Aim J, Aronson S, Gustafsson J, Hagenas L, Hager A, Ivarsson S, Karlberg J, Kristrom B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgard C, Westgren U, Westphal O, Aman J: Improved final height in girls with Turner’s syndrome treated with growth hormone and oxandrolone. J Clin EndocrMetab 1996;81(2):635-640.
11. Haeusler G, Schmitt K, Blumcl P, Plochl E, Waldhor Th, Frisch H: Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr 1996:85: 1408-1414.
12. Rosenfeld RG, Attic KM, Frane J, Brasel JA, Burstein S, Cara JF, Chemausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ: Growth hormone therapy of Turner syndrome: beneficial effect on adult height. J Paediatr 1997, in press.
13. Voss LD, Wilkin TJ, Bailey BJR, Betts PR: The reliability of height and height velocity in the assessment of growth (The Wessex Growth Study). Arch Dis Child 1991:66:833-837.
14. Ranke MB, Stubbe P, Majewski F, Bierich JR: Spontaneous growth in Turner's syndrome. Acta Paediatr Scand 1988:343(suppl):22-30.
15. Lyon AJ, Preece MA, Grant DB: Growth curve for girls w ith Turner syndrome. Arch Dis Child 1985:60:932-935.
16. Karlberg J, Albertsson-Wikland K, Nacraa RW, Rongen Westerlaken C, Wit J-M: Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects: in Hibi I. Takano K (eds): International Congress Series, No. 1014. Basic and clinical approach to Turner syndrome (3rd International Symposium on Turner syndrome.) Amsterdam. Elsevier Science. 1993. pp 83-92.
17. Rochiccioli P, David M, Malpeuch G, Colie M, Limal JM, Batlin J, Mariani R, Sultan C, Ni-velon JL, Simonin G, Bost M, Chatclain P, Bertrand AM, Freycon R, Bouquier JJ. Pierron P: Study of final height in Turner's syndrome: ethnic and genetic influences. Acta Paediatr 1994:83:305-308.
18. Chu CE, Donaldson MDC, Kelnar CJH, Smail PJ, Greene SA, Paterson WF, Connor JM: Possible role of imprinting in the Turner phenotype. J Med Genet 1994;31:840-842.
19. Ranke MB and Guilbraud O, Lindberg A, Cole T: Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia international Growth Study. Acta Paediatr Scand 1993:39 1(suppl): 82-88.
20. Price DA, Albertsson-Wikland K, on behalf of the International Board of the Kabi Pharmacia International Growth Study: Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. Acta Paediatr 1993:391 (suppl):69-74.
21. Joss EE, Mullis PE, Werder EA, Partsch CJ, Sippell WG: Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: When should therapy be started in Turner syndrome? Hormone Research 1997:47:102-109.
22. Bertrand AM, Chaussain JL, Job B, Mariani R, Ponte C, Rappaport R, Rochiccioli P, Châtelain P: Three years of GH treatment in Turner's syndrome: complex effect of GH dosage on growth parameters. Clin Endocrinol 1996; 44:665-671.
23. Rosenfeld RG, the Genetech National Cooperative Study Group: Growth hormone therapy in Turner's syndrome: and update on final height. Acta Paediatr 1992;383(suppl):3-8.
24. Van Teueunenbroek A, Keizer Schrama SMPFDM, Stijnen T, Jansen M, Otten BJ. De-lemarrc Van deWaal HA, Vulsma T, Wit JM, Rouwe CW, Reeser HM, Gosen JJ, Rogen Westerlaken C, Drop SLS: Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. J Clin Endocr Metab, 1996;81:4013-4021.
25. Massa G, Macs M, Heinrichs C, Vandeweghe M, Cracn M, Vanderschueren-Lodcweyckx M: Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome. Clin Endocrinol 1993:38:253-260.